Literature DB >> 33437869

Pain Alleviation and Opioid Weaning in an 80-Year-Old with Chronic Foot Pain Following Injection Therapy with Perineural Dexmedetomidine and Dexamethasone.

Amnon A Berger1, Ivan Urits1, Jamal Hasoon1, Alan D Kaye2, Omar Viswanath3,4,5, Jonathan Eskander6.   

Abstract

Opiates are routinely used for chronic pain patients, and up to 44% of them will have a prescription for an opiate medication for pain alleviation. However, of the 76 million adults prescribed opiates for pain management, about 12% report misuse, and a large number of these may find themselves addicted to opioid medications. Opioid addiction is an ongoing epidemic, costing many lives. Withdrawal is very difficult. This requires providers to consider alternative analgesic plans and minimize opiate use. Here we report the use of a dexamethasone-dexmedetomidine combination for a regional nerve block in an elderly woman chronically treated with opiate medications who had previously failed opiate weaning. Following her nerve block, she was able to completely wean off of opioids and continues having good pain control with an opioid-free regimen. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ).

Entities:  

Keywords:  Dex-Dex; chronic pain; opioid withdrawal; pain therapy

Year:  2021        PMID: 33437869      PMCID: PMC7790527          DOI: 10.1055/s-0040-1722176

Source DB:  PubMed          Journal:  Surg J (N Y)        ISSN: 2378-5128


  6 in total

1.  Chronic pain prevalence and analgesic prescribing in a general medical population.

Authors:  J David Clark
Journal:  J Pain Symptom Manage       Date:  2002-02       Impact factor: 3.612

2.  Dexamethasone and Dexmedetomidine as an Adjuvant to Intraarticular Bupivacaine for Postoperative Pain Relief in Knee Arthroscopic Surgery: A Randomized Trial.

Authors:  Seham M Moeen; Islam K Ramadan; Hesham A Elkady
Journal:  Pain Physician       Date:  2017-11       Impact factor: 4.965

3.  Synergistic effect of local dexamethasone and dexmedetomidine (Dex-Dex) in extending the analgesic effect of a transversus abdominis plane block prior to inguinal hernia repair.

Authors:  Jared Herman; Ivan Urits; Jamal Hasoon; Omar Viswanath; Alan D Kaye; Richard D Urman; Jonathan P Eskander
Journal:  J Clin Anesth       Date:  2020-02-01       Impact factor: 9.452

4.  Trends in Intentional and Unintentional Opioid Overdose Deaths in the United States, 2000-2017.

Authors:  Mark Olfson; Lauren M Rossen; Melanie M Wall; Debra Houry; Carlos Blanco
Journal:  JAMA       Date:  2019-12-17       Impact factor: 56.272

5.  Synergistic effect of perineural dexamethasone and dexmedetomidine (Dex-Dex) in extending the analgesic duration of a transversus abdominis plane block.

Authors:  Jared Herman; Ivan Urits; Richard D Urman; Alan D Kaye; Omar Viswanath; Jonathan P Eskander
Journal:  J Clin Anesth       Date:  2020-02-25       Impact factor: 9.452

Review 6.  Brain Reward Circuits in Morphine Addiction.

Authors:  Juhwan Kim; Suji Ham; Heeok Hong; Changjong Moon; Heh-In Im
Journal:  Mol Cells       Date:  2016-08-09       Impact factor: 5.034

  6 in total
  2 in total

1.  Superior Block Length and Reduced Opioid Use with Dexmedetomidine and Dexamethasone regional block versus plain Ropivacaine: a retrospective trial.

Authors:  Amnon A Berger; Zuby Syed; Lianne Ryan; Christopher Lee; Jamal Hasoon; Ivan Urits; Omar Viswanath; Elyse M Cornett; Alan D Kaye; Jonathan P Eskander
Journal:  Orthop Rev (Pavia)       Date:  2022-04-25

Review 2.  Efficacy of Dry Needling and Acupuncture in the Treatment of Neck Pain.

Authors:  Amnon A Berger; Yao Liu; Luke Mosel; Kristin A Champagne; Miriam T Ruoff; Elyse M Cornett; Alan David Kaye; Farnad Imani; Asadollah Shakeri; Giustino Varrassi; Omar Viswanath; Ivan Urits
Journal:  Anesth Pain Med       Date:  2021-04-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.